HTBC TechBio.
By Leigh Brody
Posted
Hosted by
Introducing the HTBC TechBio
The HTBC debuts the TechBio Chapter to put the intersection of biology and technology in the spotlight. Led by Leigh Brody, Investment Manager AlbionVC, the sessions welcome founders, operators, and investors to gather over breakfast, the most important meal of the day, for engaging discussions and networking opportunities within the dynamic field of techbio.
The format is a facilitated roundtable discussions with guest speakers or experts, encouraging all attendees to bring questions, insights, and ideas to the breakfast table.
The inaugural TechBio event will set the stage for this innovative frontier that converges biology and technology. This intersection promises a new playbook for tackling complex challenges across biological understanding, AI drug discovery, digital health and clinical research. Join us as discuss the current state of the field, key challenges and driver, and future prospects.
The HTBC TechBio breakfasts will occur quarterly, so if you can’t make this one be sure to keep in touch for future events.
This month’s panel will be made up of:
- Javier Nunez-Vicandi – Senior Associate, Sofinnova Partners
- Paul Ashley – Director, External Innovation, Data Science and Digital Health, Johnson & Johnson
- Ali Eslami – Director, Google DeepMind
- Richard Hebdon – Director Health & Life Sciences, Innovate UK
Many thanks to HSBC Innovation for hosting us this quarter at their offices!